However, during treatment, changes in antibody levels may become more useful, with a relative reduction early in therapy predicting response and complete PLA2R-Ab depletion preceding CR [12, 18, 22]
However, during treatment, changes in antibody levels may become more useful, with a relative reduction early in therapy predicting response and complete PLA2R-Ab depletion prec
Antinuclear antibody (ANA), extractable nuclear antigen (ENA), anti-double stranded DNA (anti-dsDNA) as well as the -panel for myositis-specific and myositis-associated aAbs (Euroimmun, Luebeck, Germany) were harmful
Antinuclear antibody (ANA), extractable nuclear antigen (ENA), anti-double stranded DNA (anti-dsDNA) as well as the -panel for myositis-specific and myositis-associated aAbs (Eu
2012;73:1204C1215
2012;73:1204C1215. in brain lysates using the biosensor assay, reduced microglial activation, and improved cognitive deficits. These data imply a central role for extracellular
Detoxification/Medication or Placebo Phase (days 4C8) On days 4C8, no morphine was administered
Detoxification/Medication or Placebo Phase (days 4C8) On days 4C8, no morphine was administered. significant findings, the study was terminated early. On the study day time 5 MH
Our findings claim that eGFP over-expression activates a CaMKII-dependent signaling pathway leading to cardiomyopathy
Our findings claim that eGFP over-expression activates a CaMKII-dependent signaling pathway leading to cardiomyopathy. Technological). 3. Outcomes 3.1. eGFP appearance in transg